Alembic Pharmaceuticals Limited (APLLTD.NS)
Alembic Pharmaceuticals Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vadodara, GU, IN. The stock last traded at $831.25, up 0.01% on the session, giving a market capitalisation of $163.39B. Its beta of 0.30 implies it has historically moved less than the broad market.
Alembic Pharmaceuticals Limited is a pharmaceutical firm that develops, manufactures, and markets medicinal products both domestically in India and across international markets. Its offerings encompass active pharmaceutical ingredients (APIs) and a wide array of formulations. The company provides both proprietary (branded) and generic medications, addressing numerous therapeutic needs such as cardiovascular health, women's health, gastrointestinal issues, eye and skin conditions, kidney/urinary tract disorders, orthopedic ailments, anti-infective treatments, remedies for cold and cough, and anti-diabetic management. Furthermore, the company engages in the export of its diverse product portfolio. Founded in 1907, Alembic Pharmaceuticals Limited maintains its main office in Vadodara, India.
Alembic Pharmaceuticals Limited is most often compared with the following Healthcare names: